Life Science Company News

Reset
Results 181 - 200 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Revolo Biotherapeutics Announces the Completion of Phase 1 Multiple Ascending Dose Clinical Trial of ‘1104

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Revolo Biotherapeutics

Replay announces partnership between product company Syena and JURA Bio to advance T cell receptor NK therapies in cancer

Read more ››
By: GlobeNewswire - 21 Sep 2023

Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Atreca, Inc.

Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Outlook Therapeutics, Inc.

Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million

Read more ››
By: GlobeNewswire - 21 Sep 2023

Osteal Therapeutics Closes $23M Series C Financing

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Osteal Therapeutics

Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at 2023 Annual European Association of Neuro-Oncology Meeting (EANO)

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Biodexa Pharmaceuticals PLC

Gradalis to Participate in the Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Gradalis, Inc.

SELLAS Announces Positive Topline Data in Lymphoma Cohort from SLS009 Phase 1 Dose-Escalation Trial, Supporting Advancement to Phase 2 Clinical Study; Primary and Secondary Endpoints Met

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  SELLAS Life Sciences Group, Inc.

Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

Read more ››
By: GlobeNewswire - 21 Sep 2023

Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Genprex, Inc.

ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  ProSomnus Inc.

Checkpoint Therapeutics to Participate in the Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Checkpoint Therapeutics, Inc.

U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Immix Biopharma, Inc.

Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Paratek Pharmaceuticals, Inc.

Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Elevar Therapeutics, Inc.

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Precipio, Inc.

Cage-Free Repair Releases 2023 Cannabis Social Responsibility Report

Read more ››
By: GlobeNewswire - 21 Sep 2023

Relievant Medsystems Introduces Intracept Simulator System Powered by Medability for Improved and Expanded Physician Training Opportunities

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Relievant Medsystems, Inc.

Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Krystal Biotech, Inc.
Results 181 - 200 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »